Bremelanotide / melanocortin agonist | Research grade | Lyophilised powder
PT-141 (10mg)
For laboratory research purposes only. Not for human consumption. Not a medicine, supplement, or cosmetic. Intended for controlled laboratory and in vitro use only.
Also available: 10-vial kit — $594.95
PT-141 for melanocortin pathway research
PT-141 (bremelanotide) is a synthetic cyclic heptapeptide melanocortin receptor agonist studied in receptor pharmacology and CNS pathway literature. The Protocol supplies PT-141 as a lyophilised powder for controlled laboratory research.
This catalogue listing is for research inventory only. It is not offered as a medicine, consumer, or cosmetic product.
What it's for
PT-141 (bremelanotide; CAS 189691-06-3) is a synthetic cyclic heptapeptide melanocortin receptor agonist studied in laboratory CNS and receptor literature. Research-model framing includes:
- Melanocortin receptor (including MC3R / MC4R) binding and signalling assays in vitro
- Comparative melanocortin agonist panels alongside related research peptides
- Central pathway models that specify bremelanotide / PT-141 research material
- Identity-confirmed inventory for protocols citing PT-141 in receptor pharmacology literature
Specifications
| Stock code | P41 |
|---|---|
| Cap colour | Red |
| Synonyms | Bremelanotide, PT141 |
| CAS number | 189691-06-3 (confirm on batch COA) |
| Chemical formula | C50H68N14O10 (typical literature value) |
| Molecular weight | Approx. 1025.2 g/mol (as per batch COA) |
| Form | White to off-white lyophilised powder |
| Purity | ≥99.0% (COA validated) |
| Solubility | Soluble in sterile research solvents as per lab protocol |
| Quality checks | RP-HPLC identity/purity assessment; third-party verification where listed |
| Net content | 10mg per vial |
Storage and handling
- Store dry at 2–8°C unless your batch documentation states otherwise.
- Protect from moisture, light, and repeated temperature cycling.
- Reconstitute only under trained laboratory procedures using suitable sterile solvents.
- Follow your organisation’s SOPs for labelling, use, and disposal.
Calculate
Vial dilution lab-math
Acknowledgement required
Confirm the research-use acknowledgement to unlock controls and calculate.
Open full calculatorWhat is included
- 1 × PT-141, 10mg lyophilised vial
- Protective inner packing
- Access to batch-specific COA where available
- Australia Post tracking after dispatch
Quality signals
- ≥99% purity target with COA support
- Third-party laboratory verification on listed batches
- Tamper-evident packing checks before dispatch
- Clear product labelling for research inventory control
Request batch documentation on the Quality & testing page (COA on request for verified lots).
Related research materials
- PT-141 (10mg) — 10 Vial Kit — $594.95
Product FAQ
Is this lab tested?+
Listed batches are assessed for purity and identity, with Certificates of Analysis available on request for verified lots.
How fast is Australian delivery?+
Express Australia Post typically runs 1 to 3 business days after dispatch, depending on destination.
Is outer packaging discreet?+
Yes. Outer cartons use plain labelling without product descriptors.
What is the literature identity of PT-141?+
PT-141 is also known as bremelanotide (CAS 189691-06-3 in common references). Confirm molecular parameters on your batch Certificate of Analysis. This listing is research inventory only.
How should PT-141 research material be stored?+
Store dry at 2–8°C unless your batch documentation states otherwise. Protect from moisture, light, and repeated temperature cycling under laboratory SOP.
This product and its description are intended solely for laboratory and controlled research use. Nothing on this page is medical advice, dosing guidance, or an invitation for personal use. Not for human consumption. See also the Research Use Disclaimer. For research purposes only. Not for human consumption. Not a medicine, supplement, or cosmetic. Laboratory and in vitro use only.
